Research graph
References from Ultrasound-based transient elastography combined with metabolic biomarkers enhances the diagnostic efficacy for pediatric MASLD. Local targets link to admitted publications; unresolved targets remain external evidence.
Meta analysis of the prevalence and risk factors of non-alcoholic fatty liver disease in overweight and obese children and adolescents in China.
2025 · External reference
NAFLD in adolescents aged 10-19: global burden of disease analysis from 1990 to 2021.
10.1097/md.0000000000045051 · 2025 · External reference
Nonalcoholic fatty liver disease 2020: the state of the disease.
10.1053/j.gastro.2020.01.052 · 2020 · External reference
Review of clinical guidelines in the diagnosis of pediatric nonalcoholic fatty liver disease.
10.1002/cld.1094 · 2021 · External reference
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease.
10.4254/wjh.v15.i5.609 · 2023 · External reference
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
10.1016/j.jhep.2016.12.022 · 2017 · External reference
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver.
10.1016/j.ultrasmedbio.2015.03.007 · 2015 · External reference
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.
10.1016/j.jhep.2013.12.018 · 2014 · External reference
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
10.1111/j.1478-3231.2012.02781.x · 2012 · External reference
Recent advances in the epidemiology of nonalcoholic fatty liver disease in children.
10.1111/ijpo.12849 · 2021 · External reference
Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies.
10.1016/j.tem.2016.11.006 · 2017 · External reference
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
10.1002/hep.24001 · 2010 · External reference
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
10.1002/hep.28843 · 2017 · External reference
Determination of reliability criteria for liver stiffness evaluation by transient elastography.
10.1002/hep.25993 · 2013 · External reference
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
10.2307/2531595 · 1988 · External reference
The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children.
10.1002/hep4.1983 · 2022 · External reference
Transient elastography in the diagnosis of pediatric non-alcoholic fatty liver disease and its subtypes.
10.3389/fped.2022.808997 · 2022 · External reference
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
10.1186/s12887-019-1485-8 · 2019 · External reference
Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter.
10.14366/usg.21246 · 2022 · External reference
Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
10.1111/liv.12024 · 2013 · External reference
Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.
10.1038/s41598-021-84674-z · 2021 · External reference
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.
10.1152/ajpcell.00600.2006 · 2007 · External reference
Non-invasive approaches to estimate liver steatosis and stiffness in children with non-alcoholic fatty liver disease.
10.1097/mpg.0000000000003371 · 2022 · External reference
Review of clinical guidelines in the diagnosis of pediatric nonalcoholic fatty liver disease.
10.1002/cld.1094 · ExternalCitation · doi-reference
Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
10.1002/hep.24001 · ExternalCitation · doi-reference
Determination of reliability criteria for liver stiffness evaluation by transient elastography.
10.1002/hep.25993 · ExternalCitation · doi-reference
Improved noninvasive prediction of liver fibrosis by liver stiffness measurement in patients with nonalcoholic fatty liver disease accounting for controlled attenuation parameter values.
10.1002/hep.28843 · ExternalCitation · doi-reference
The discriminatory ability of FibroScan liver stiffness measurement, controlled attenuation parameter, and FibroScan-aspartate aminotransferase to predict severity of liver disease in children.
10.1002/hep4.1983 · ExternalCitation · doi-reference
Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations.
10.1016/j.jhep.2013.12.018 · ExternalCitation · doi-reference
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
10.1016/j.jhep.2016.12.022 · ExternalCitation · doi-reference
Mitochondrial adaptation in nonalcoholic fatty liver disease: novel mechanisms and treatment strategies.
10.1016/j.tem.2016.11.006 · ExternalCitation · doi-reference
WFUMB guidelines and recommendations for clinical use of ultrasound elastography: Part 3: liver.
10.1016/j.ultrasmedbio.2015.03.007 · ExternalCitation · doi-reference
Hepatic lymphocytes involved in the pathogenesis of pediatric and adult non-alcoholic fatty liver disease.
10.1038/s41598-021-84674-z · ExternalCitation · doi-reference
Nonalcoholic fatty liver disease 2020: the state of the disease.
10.1053/j.gastro.2020.01.052 · ExternalCitation · doi-reference
NAFLD in adolescents aged 10-19: global burden of disease analysis from 1990 to 2021.
10.1097/md.0000000000045051 · ExternalCitation · doi-reference
Non-invasive approaches to estimate liver steatosis and stiffness in children with non-alcoholic fatty liver disease.
10.1097/mpg.0000000000003371 · ExternalCitation · doi-reference
Recent advances in the epidemiology of nonalcoholic fatty liver disease in children.
10.1111/ijpo.12849 · ExternalCitation · doi-reference
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography.
10.1111/j.1478-3231.2012.02781.x · ExternalCitation · doi-reference
Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease.
10.1111/liv.12024 · ExternalCitation · doi-reference
Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress.
10.1152/ajpcell.00600.2006 · ExternalCitation · doi-reference
Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
10.1186/s12887-019-1485-8 · ExternalCitation · doi-reference
Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter.
10.14366/usg.21246 · ExternalCitation · doi-reference
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.
10.2307/2531595 · ExternalCitation · doi-reference
Transient elastography in the diagnosis of pediatric non-alcoholic fatty liver disease and its subtypes.
10.3389/fped.2022.808997 · ExternalCitation · doi-reference
Noninvasive biomarkers in pediatric nonalcoholic fatty liver disease.
10.4254/wjh.v15.i5.609 · ExternalCitation · doi-reference
